Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield

NCT02324647 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 807

Last updated 2026-01-07

No results posted yet for this study

Summary

Standard diagnostic work-up for adrenal incidentalomas (AI) consists of periodical biochemical analysis and CT-scanning in case the initial work-up does not demonstrate the presence of hormonal hypersecretion or adrenocortical carcinoma (ACC), respectively. The overall aim of this study is to improve the cost-effectiveness of the diagnostic strategy for AI. Cost-effectiveness of urine steroid profiling (USP) will be compared to the standard diagnostic strategy of repeated CT-imaging.

Conditions

  • Adrenal Incidentaloma
  • Adrenocortical Carcinoma

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER
  • Amsterdam UMC, location VUmc

    collaborator OTHER
  • Radboud University Medical Center

    collaborator OTHER
  • Leiden University Medical Center

    collaborator OTHER
  • Maastricht University Medical Center

    collaborator OTHER
  • UMC Utrecht

    collaborator OTHER
  • Erasmus Medical Center

    collaborator OTHER
  • Martini Hospital Groningen

    collaborator OTHER
  • Canisius-Wilhelmina Hospital

    collaborator OTHER
  • Diakonessenhuis, Utrecht

    collaborator OTHER
  • Isala

    collaborator OTHER
  • Haga Hospital

    collaborator OTHER
  • St. Antonius Hospital

    collaborator OTHER
  • Kennemer Gasthuis

    collaborator OTHER
  • Maxima Medical Center

    collaborator OTHER
  • Medical Center Alkmaar

    collaborator OTHER
  • Frisius Medisch Centrum

    collaborator OTHER
  • Meander Medical Center

    collaborator OTHER
  • Medisch Spectrum Twente

    collaborator OTHER
  • Onze Lieve Vrouwe Gasthuis

    collaborator OTHER
  • Rijnstate Hospital

    collaborator OTHER
  • Elisabeth-TweeSteden Ziekenhuis

    collaborator OTHER
  • Tergooi Hospital

    collaborator OTHER
  • Vlietland Ziekenhuis

    collaborator OTHER
  • Treant ziekenhuis

    collaborator UNKNOWN
  • Flevoziekenhuis

    collaborator OTHER
  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • Michiel N Kerstens, MD, PhD · University Medical Center Groningen

  • E Buitenwerf, MD · University Medical Center Groningen

  • P.H.L.T. Bisschop, MD, PhD · Amsterdam UMC, location VUmc

  • E.M.W. Eekhoff, MD, PhD · Free University UMC Amsterdam

  • E.P.M. van der Kleij-Corssmit, MD, PhD · Leiden University Medical Center

  • R.A. Feelders, MD, PhD · Erasmus Medical Center

  • B. Havekes, MD, PhD · Maastricht University Medical Center

  • H.J.L.M Timmers, MD, PhD · UMC St Radboud Nijmegen

  • G.D. Valk, MD, PhD · UMC Utrecht

  • P.H.N. Oomen, MD, PhD · medical center leeuwarden

  • K.M. van Tol, MD, PhD · Martini Hospital Groningen

  • R.S.M.E. Wouters, MD · Scheper Hospital

  • A.A.M. Franken, MD, PhD · Isala

  • J.R. Meinardi, MD, PhD · Canisius-Wilhelmina Hospital

  • R. GrooteVeldman, MD, PhD · Medisch Spectrum Twente

  • P.C. Oldenburg-Ligtenberg, MD, PhD · Meander Medical Center

  • A.F. Muller, MD, PhD · Diakonessenhuis, Utrecht

  • M.O. van Aken, MD, PhD · Haga Hospital

  • W. de Ronde, MD, PhD · Kennemer Gasthuis

  • H.R. Haak, MD, PhD · Maxima Medical Center

  • S. Simsek, MD, PhD · Medical Center Alkmaar

  • I.M.M.J. Wakelkamp, MD, PhD · St. Antonius Hospital

  • I.I.L. Berk-Planken, MD, PhD · Vlietland Ziekenhuis

  • P.S. van Dam, MD, PhD · Onze Lieve Vrouwe Gasthuis

  • H. de Boer, MD, PhD · Rijnstate Hospital

  • J.J.J. de Sonnaville, MD, PhD · Tergooi Hospital

  • E. Donga, MD · St.Elisabeth Hospital

  • N. Smit, MD · Flevoland Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02324647 on ClinicalTrials.gov